Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration

Acta Ophthalmologica

Volumn 88, Issue 4, 2010, Pages 426-430

  Odergren, Anne ^a   Algvere, Peep V ^a   Seregard, Stefan ^a   Libert, Carina ^a   Kvanta, Anders ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Age related macular degeneration; Diodlaser; Experimental treatment; Photodynamic therapy; Quality of life; Transpupillary thermotheraly

Indexed keywords

VERTEPORFIN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIODE LASER; DOSE RESPONSE; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RETINA MACULA AGE RELATED DEGENERATION; SCORING SYSTEM; TRANSPUPILLARY THERMOTHERAPY; TREATMENT RESPONSE;

CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; PUPIL; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VISUAL ACUITY;

EID: 77952861647     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01567.x     Document Type: Article

References (12)

1. Brown DM, Kaiser PK, Michels M et al. (2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 : 1432 1444.
2. Cahill MT, Banks AD, Stinnett SS Toth CA (2005 Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 112 : 152 158.
3. Chang TS, Bressler NM, Fine JT et al. (2007 Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 125 : 1460 1469.
4. Clemons TE, Chew EY, Bressler SB McBee W (2003 National Eye Institute Visual Function Questionnaire in Age-Related Eye Disease Study (AREDS): AREDS report no. 10. Arch Ophthalmol 121 : 211 217. (Pubitemid 36184034)
5. Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C Lee PP (1998 Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116 : 227 233. (Pubitemid 128719461)
6. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S Hays RD (2001 Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Arch Ophthalmol 119 : 1050 1058.
7. Miskala PH, Hawkins BS, Mangione CM Bass EB (2003 Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization. Arch Ophthalmol 121 : 531 539.
8. Miskala PH, Bass EB, Bressler NM et al. (2004 Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life finding: SST report no. 12. Ophthalmology 111 : 1981 1992.
9. Odergren A, Algvere PV, Seregard S Kvanta A (2008 A prospective randomized study on low dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration. Br J Ophthalmol 92 : 757 761.
10. Rosenfeld PJ, Brown DM, Heier JS et al. (2006 Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 : 1419 1431.
11. Slakter JS, Bochow TW, D'Amico DJ et al. (2006 Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology 113 : 3 13.
12. Varma R, Wu J, Chong K, Azen SP Hays RD (2006 Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113 : 1846 1853.